✦ LIBER ✦

Focus on Mechanisms of Inflammation in Inflammatory Bowel Disease Sites of Inhibition: Current and Future Therapies

✍ Scribed by Van Assche, Gert; Vermeire, Séverine; Rutgeerts, Paul

Book ID: 122992618
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 306 KB
Volume: 35
Category: Article
ISSN: 0889-8553
DOI: 10.1016/j.gtc.2006.09.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The basis of current and future therapy

The basis of current and future therapy for inflammatory bowel disease

✍ Charles O. Elson 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 821 KB

The role of antibiotic and probiotic the

The role of antibiotic and probiotic therapies in current and future management of inflammatory Bowel disease

✍ Julia B. Ewaschuk; Qassim Z. Tejpar; Isaac Soo; Karen L. Madsen; Richard N. Fedo 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 171 KB

Influence of Disease Site and Activity o

Influence of Disease Site and Activity on Peripheral Neutrophil Function in Inflammatory Bowel Disease

✍ Anna D'odorico; Renata D'inca; Cinzia Mestriner; Vincenza Di Leo; Antonio Ferron 📂 Article 📅 2000 🏛 Springer US 🌐 English ⚖ 459 KB

Expression of Syndecan-1 in Inflammatory

Expression of Syndecan-1 in Inflammatory Bowel Disease and a Possible Mechanism of Heparin Therapy

✍ Richard Day; Mohammad Ilyas; Peter Daszak; Ian Talbot; Alastair Forbes 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 484 KB

Role of commensal and probiotic bacteria

Role of commensal and probiotic bacteria in human health: a focus on inflammatory bowel disease

✍ Rebeca Martín, Sylvie Miquel, Jonathan Ulmer, Noura Kechaou… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 500 KB

Applications of proteomics in the study

Applications of proteomics in the study of inflammatory bowel diseases: Current status and future directions with available technologies

✍ Philip Alex; Marjan Gucek; Xuhang Li 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 392 KB 👁 1 views

Inflammatory bowel diseases (IBD) are chronic, heterogeneous, and multifactorial intestinal inflammatory disorders. Major challenges in IBD research include identification of major pathogenic alterations of genes/proteins as well as effective biomarkers for early diagnosis, prognosis, and prediction